TGFB1 and epilepsy: Conclusion: Our findings suggest that non-SMAD/ TGF-β signaling pathway actas critical target in epilepsy, and also rationalizes the ISOX as a promising newerneuroprotective, anti-inflammatory, and disease-modifying agent in forestalling theepileptogenesis